NCT00929734View on ClinicalTrials.gov

Effect of Rosuvastatin Therapy in Patients With Stable Chronic Obstructive Pulmonary Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

99

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Interventions
DRUG

Rosuvastatin

10mg tablets, once daily in three months

DRUG

Placebo

1 tablet, once daily in three months

Trial Locations (1)

1478

Akershus University Hospital, Lørenskog

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

collaborator

Haukeland University Hospital

OTHER

lead

University Hospital, Akershus

OTHER